Skip to main content

H.R. 830

Referred to Committee

SAFE Act

Introduced 1/31/2025•119th Congress•House

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1/31/2025 • House

Summary

Save Americans from the Fentanyl Emergency Act or the SAFE Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025.

It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.

The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

Introduced in House • 1/31/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDepartment of JusticeDrug trafficking and controlled substancesGovernment studies and investigationsInternational law and treatiesLicensing and registrationsManufacturingResearch administration and funding

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (18)

Party Breakdown

15
Democrats
3
Republicans
0
Independents

Sponsor

R[
Rep. Pappas, Chris [D-NH-1]

Democrat • NH-1

Sponsored 1/31/2025

Cosponsors (17)

R[
R[
Rep. Newhouse, Dan [R-WA-4]

R-WA-4

Joined 1/31/2025

R[
Rep. Crow, Jason [D-CO-6]

D-CO-6

Joined 2/4/2025

R[
Rep. Houlahan, Chrissy [D-PA-6]

D-PA-6

Joined 2/4/2025

R[
Rep. Figures, Shomari [D-AL-2]

D-AL-2

Joined 2/4/2025

R[
Rep. Craig, Angie [D-MN-2]

D-MN-2

Joined 2/4/2025

Bill Journey

Originated in the House

Introduced

January 31, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House1/31/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors17